Provided by Tiger Trade Technology Pte. Ltd.

CARSGEN-B

12.600
+0.1501.20%
Volume:2.95M
Turnover:36.66M
Market Cap:7.48B
PE:-71.08
High:12.750
Open:12.680
Low:12.050
Close:12.450
52wk High:28.600
52wk Low:10.870
Shares:594.00M
HK Float Shares:594.00M
Volume Ratio:1.43
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.177
ROE:-9.57%
ROA:-8.91%
PB:5.82
PE(LYR):-71.08
PS:46.89

Loading ...

CARsgen Therapeutics Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 06

CARsgen Therapeutics Receives China IND Clearance for Multiple Myeloma Therapy; Shares Up 3%

MT Newswires Live
·
Aug 04

Carsgen Therapeutics Says Ct0596 Receives IND Clearance from NMPA

Reuters
·
Aug 04

China's Nod Granted to CARSGEN-B's BCMA-Targeting Universal CAR-T for Hard-to-Treat Myeloma

Stock News
·
Aug 04

CARsgen Secures NMPA IND Clearance for Allogeneic BCMA CAR-T Candidate CT0596 in Relapsed/Refractory Multiple Myeloma

Bulletin Express
·
Aug 04

CARsgen Says Ct0596 Wins NMPA IND Clearance for Relapsed/refractory Multiple Myeloma

Reuters
·
Aug 04

CARsgen Therapeutics - Ct0596 Receives Ind Clearance from Nmpa for Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS
·
Aug 04

CARsgen Therapeutics Holdings (SEHK:2171) Gains Clinical Momentum Following Satri Cel Trial Update But Looks Pricey

Simply Wall St.
·
Jul 27

CARSGEN-B Allocates HK$4.98 Million for Share Buyback on July 17

Stock News
·
Jul 17

Carsgen Files HKEX Next-day Disclosure Return, Issues 2,000 New Shares Via Option Exercise

Reuters
·
Jul 17

Movement Alert|CARsgen Therapeutics-B Falls 6.03% in Regular Trading, Biotech Sector Under Broad Selling Pressure

Market Focus
·
Jul 17

CARSGEN-B Shares Surge Over 7% in Session as CT041 Passes Initial Review for 2026 Commercial Health Insurance Innovation Drug Catalog

Deep News
·
Jul 16

Movement Alert|CARsgen Therapeutics-B Rises 5.51% in Regular Trading, Kelimei Post-Surgical Consolidation Therapy Positive Results Accepted for ESMO Poster Presentation

Market Focus
·
Jul 16

Hong Kong Stocks Midday Update: Hang Seng Index Rises 1.46%, Innovation Pharma Soars

Stock News
·
Jul 15

Shares of CARSGEN-B Surge Over 6% Ahead of Key Study Presentation at 2026 ESMO Congress

Stock News
·
Jul 15

Movement Alert|CARsgen Therapeutics Rises 5.23% in Regular Trading, Satri-Cel Post-Surgical Consolidation Trial Results Accepted for ESMO Poster Presentation

Market Focus
·
Jul 15

CARsgen’s Satri-cel Shows No Post-operative Recurrence in IIT; Data Accepted for Presentation at ESMO 2026

Bulletin Express
·
Jul 15

Carsgen Says Satri-cel Gastric Cancer Consolidation Trial Shows no Recurrences to Date

Reuters
·
Jul 15

Carsgen Files HKEX Next-day Disclosure Return Reporting Share Repurchase and Cancellation

Reuters
·
Jul 07

CARsgen Keeps Share Structure Steady in June 2026; 17.68 Million Options Remain Outstanding

Bulletin Express
·
Jul 07